Cat. No.: DAB-0012261
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Host Species | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Applications | WB |
| Product Description | Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human MDH2 protein. Antibodies are purified by protein A and peptide affinity chromatography. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | MDH2 |
| UniProt No. | P40926 |
| Gene ID | 4191 |
| Gene Description | Malate dehydrogenase is a key enzyme in the tricarboxylic acid cycle and malate/aspartate shuttle. MDH is widely expressed in organisms from most bacteria to all eukaryotes. The cytoplasmic MDH isoenzyme primarily reduces oxaloacetate to malate in the malate/aspartate shuttle. The major function of the mitochondrial MDH isoenzyme is to oxidize malate to oxaloacetate in the tricarboxylic acid cycle. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
